Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2 therapy in relapsed acute myelogenous leukemiaG Meloni, M Vignetti, E Pogliani, et al.
American Journal of Hematology|June 13, 1998
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemiaM Montillo, S Mirto, M C Petti, et al.
Leukemia|February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative GroupA M Carella, P Carlier, E Pungolino, et al.
The Science of the Total Environment|March 3, 2019
Biogenic habitat shifts under long-term ocean acidification show nonlinear community responses and unbalanced functions of associated invertebratesM Milazzo, C Alessi, F Quattrocchi, et al.
Aquaculture (Amsterdam, Netherlands)|October 21, 2022
The stakeholder's perception of socio-economic impacts generated by COVID-19 pandemic within the Italian aquaculture systemsS Mirto, V Montalto, M C M Mangano, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
British Journal of Haematology|November 25, 2000
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo, A Tedeschi, L Pagano, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2006
Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre studyA Andriani, A Zullo, F Di Raimondo, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Pageof 4